Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Enoxaparin (60mg) Injection
Therapeutic Category
Anticoagulant, Cardiovascular, Cardiology
Dosage Form
Injection
Packaging Type
Vial + W.F.I. + Tray
Packaging
0.6ml
Price
₹717/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ebonoxa 60 Injection contains Enoxaparin (60mg), a low-molecular-weight heparin (LMWH) that works as an anticoagulant to prevent and treat various thromboembolic disorders. It is primarily used in the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing surgery or those with certain medical conditions that put them at risk for blood clots.
This medication also plays a crucial role in managing unstable angina and certain other cardiovascular conditions. By inhibiting clot formation, Ebonoxa 60 helps prevent the development of dangerous blood clots, thereby reducing the risk of stroke, heart attack, and other serious complications.
Common side effects may include bleeding, bruising, low platelet count (thrombocytopenia), and elevated liver enzymes.
Prevention and treatment of thromboembolic events such as DVT and PE, and management of unstable angina.
For subcutaneous injection only. Follow healthcare provider's instructions for proper use and dosage.
Store in a cool, dry place at room temperature (15-25°C). Protect from light and avoid freezing. Keep out of reach of children.
Composition : Enoxaparin (40mg) Injection
Composition : Heparin (5000IU) + Benzyl Alcohol (0.95%) Injection
Composition : Labetalol (5mg/1ml)
Composition : Tranexamic Acid (250mg) + Ethamsylate (250mg)
Composition : Tranexamic Acid (500mg)
Composition : Tranexamic Acid (500mg) Injection
Composition : Tranexamic Acid (250mg) + Glutathione (50mg)
Composition : Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Composition : Co-Enzyme Q10( Ubidecarenone) BP 100mg L-Carnitine L-Tartrate 50mg Lycopene USP 4000mcg Selenium Dioxide USP 65mcg Omega-3 Fatty Acids BP 150mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Enoxaparin 60mg Injection is a high-demand anticoagulant used in hospital and critical care settings, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong demand in DVT (deep vein thrombosis), pulmonary embolism, post-surgical clot prevention, cardiac care, ICU management, and high-risk patient anticoagulation therapy. It is widely used in hospitals, emergency wards, and surgical departments.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Enoxaparin 60mg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital procurement, ICU and surgical demand, repeat institutional orders, and strong acceptance in cardiology, orthopedics, and emergency medicine when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anticoagulant formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.